Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NOVEL LABS INC

  • FDA Approval
  • March 13, 2025, 08:43 UTC
  • 47
  • 0 comments

FDA approve TRIMETHOPRIM

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • March 13, 2025, 08:43 UTC
  • 50
  • 0 comments

FDA approve ATORVASTATIN CALCIUM

Comment Full text

ALNYLAM PHARMS INC

  • FDA Approval
  • March 13, 2025, 08:43 UTC
  • 67
  • 0 comments

FDA approve VUTRISIRAN SODIUM

Comment Full text

BAMF

  • FDA Approval
  • March 13, 2025, 08:43 UTC
  • 50
  • 0 comments

FDA approve FLUDEOXYGLUCOSE F-18

Comment Full text

SANDOZ

  • FDA Approval
  • March 13, 2025, 08:43 UTC
  • 57
  • 0 comments

FDA approve NELARABINE

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • March 13, 2025, 08:43 UTC
  • 52
  • 0 comments

FDA approve EPHEDRINE SULFATE

Comment Full text

SUN PHARM

  • FDA Approval
  • March 13, 2025, 08:43 UTC
  • 63
  • 0 comments

FDA approve BICALUTAMIDE

Comment Full text

KARYOPHARM THERAPS

  • FDA Approval
  • March 12, 2025, 15:23 UTC
  • 59
  • 0 comments

FDA approve SELINEXOR

Comment Full text

ZYDUS LIFESCIENCES

  • FDA Approval
  • March 12, 2025, 08:40 UTC
  • 67
  • 0 comments

FDA approve METHENAMINE HIPPURATE

Comment Full text

LUPIN LTD

  • FDA Approval
  • March 12, 2025, 08:40 UTC
  • 63
  • 0 comments

FDA approve DULOXETINE HYDROCHLORIDE

Comment Full text
  • Previous
  • 159
  • 160
  • 161
  • 162
  • 163
  • Next

Search

News categories

  • Technical Exchange News(10333)
  • Event(1541)
  • SEC News(176744)
  • FDA Approval(9672)
  • Company Report(721)
  • Business News(118368)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin